The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma

10.20892/j.issn.2095-3941.2017.0176

Saved in:
Bibliographic Details
Main Authors: Li, Y.Q, Khin, N.S, Chua, M.L.K
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/182097
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-182097
record_format dspace
spelling sg-nus-scholar.10635-1820972024-11-11T01:46:15Z The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma Li, Y.Q Khin, N.S Chua, M.L.K DUKE-NUS MEDICAL SCHOOL biological marker cisplatin deoxyribonuclease early antigen fluorouracil gemcitabine immunoglobulin A antibody paclitaxel virus capsid antigen virus DNA adjuvant therapy Article cancer prognosis cancer screening cancer survival carcinogenesis diagnostic accuracy DNA determination Epstein Barr virus Epstein Barr virus infection evolution gene dosage human malignant transformation nasopharynx carcinoma nonhuman overall survival predictive value progression free survival sensitivity and specificity serology treatment response virus detection 10.20892/j.issn.2095-3941.2017.0176 Cancer Biology and Medicine 15 1 1-5 2020-10-30T02:10:27Z 2020-10-30T02:10:27Z 2018 Article Li, Y.Q, Khin, N.S, Chua, M.L.K (2018). The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma. Cancer Biology and Medicine 15 (1) : 1-5. ScholarBank@NUS Repository. https://doi.org/10.20892/j.issn.2095-3941.2017.0176 20953941 https://scholarbank.nus.edu.sg/handle/10635/182097 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic biological marker
cisplatin
deoxyribonuclease
early antigen
fluorouracil
gemcitabine
immunoglobulin A antibody
paclitaxel
virus capsid antigen
virus DNA
adjuvant therapy
Article
cancer prognosis
cancer screening
cancer survival
carcinogenesis
diagnostic accuracy
DNA determination
Epstein Barr virus
Epstein Barr virus infection
evolution
gene dosage
human
malignant transformation
nasopharynx carcinoma
nonhuman
overall survival
predictive value
progression free survival
sensitivity and specificity
serology
treatment response
virus detection
spellingShingle biological marker
cisplatin
deoxyribonuclease
early antigen
fluorouracil
gemcitabine
immunoglobulin A antibody
paclitaxel
virus capsid antigen
virus DNA
adjuvant therapy
Article
cancer prognosis
cancer screening
cancer survival
carcinogenesis
diagnostic accuracy
DNA determination
Epstein Barr virus
Epstein Barr virus infection
evolution
gene dosage
human
malignant transformation
nasopharynx carcinoma
nonhuman
overall survival
predictive value
progression free survival
sensitivity and specificity
serology
treatment response
virus detection
Li, Y.Q
Khin, N.S
Chua, M.L.K
The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
description 10.20892/j.issn.2095-3941.2017.0176
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Li, Y.Q
Khin, N.S
Chua, M.L.K
format Article
author Li, Y.Q
Khin, N.S
Chua, M.L.K
author_sort Li, Y.Q
title The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
title_short The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
title_full The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
title_fullStr The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
title_full_unstemmed The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
title_sort evolution of epstein-barr virus detection in nasopharyngeal carcinoma
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/182097
_version_ 1821226152180580352